Jay Cross
Direttore Finanziario/CFO presso SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Patrimonio netto: 1 913 $ in data 30/04/2024
Profilo
John Harry Cross is currently the Chief Financial & Business Officer at Sonnet BioTherapeutics, Inc. and Sonnet BioTherapeutics Holdings, Inc. He previously worked as the Managing Director-Healthcare Investment Banking at Chardan Capital Markets LLC and as a Director at Alere Financial Partners.
He received his undergraduate degree from Washington & Lee University and his graduate degree from Yale School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 11/12/2023 | 1 087 ( 0.04% ) | 1 913 $ | 30/04/2024 |
Posizioni attive di Jay Cross
| Società | Posizione | Inizio |
|---|---|---|
| SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Direttore Finanziario/CFO | 01/05/2019 |
Sonnet BioTherapeutics, Inc.
 Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Direttore Finanziario/CFO | 01/05/2019 |
Precedenti posizioni note di Jay Cross
| Società | Posizione | Fine |
|---|---|---|
Chardan Capital Markets LLC
 Chardan Capital Markets LLC Investment Banks/BrokersFinance Chardan Capital Markets LLC is a registered broker-dealer headquartered in New York City. The firm was founded by Kerry Propper and Steve Urbach in 2003. The firm offers a range of services which include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading to institutional clients. | Corporate Officer/Principal | 01/03/2019 |
Alere Financial Partners
 Alere Financial Partners Investment ManagersFinance Alere Financial Partners provides investment research. The private company is based in King of Prussia, PA. | Direttore/Membro del Consiglio | 01/06/2015 |
Formazione di Jay Cross
| Washington & Lee University | Undergraduate Degree |
| Yale School of Medicine | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Chardan Capital Markets LLC
Chardan Capital Markets LLC Investment Banks/BrokersFinance Chardan Capital Markets LLC is a registered broker-dealer headquartered in New York City. The firm was founded by Kerry Propper and Steve Urbach in 2003. The firm offers a range of services which include capital raising, merger and acquisition advisory, strategic advisory, equity research, corporate access and institutional trading to institutional clients. | Finance |
Alere Financial Partners
Alere Financial Partners Investment ManagersFinance Alere Financial Partners provides investment research. The private company is based in King of Prussia, PA. | Finance |
Sonnet BioTherapeutics, Inc.
Sonnet BioTherapeutics, Inc. BiotechnologyHealth Technology SONNET BioTherapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of biologic drugs with single- or bi-specific mechanisms of action. Its pipeline include FHAB (Fully Human Albumin Binding), the technology utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. The company was founded by Pankaj Mohan and John K. Cini in 2015 and is headquartered in Princeton, NJ. | Health Technology |
- Borsa valori
- Insiders
- Jay Cross
